This represents a major limitation in current stroke research; while the catabolic pathways of IL-6 and TNF-α are well characterized molecularly, the lack of granular data linking them to specific functional gains (e.g., FIM scores or gait velocity) remains a critical knowledge gap that hinders their immediate clinical utility in personalized rehabilitation. This evidence concerns the gene TNF and stroke disorder.